Fructose, insulin resistance, and metabolic dyslipidemia.
Obesity and type 2 diabetes are occurring at epidemic rates in the United States and many parts of the world. The "obesity epidemic" appears to have emerged largely from changes in our diet and reduced physical activity. An important but not well-appreciated dietary change has been the substantial increase in the amount of dietary fructose consumption from high intake of sucrose and high fructose corn syrup, a common sweetener used in the food industry. A high flux of fructose to the liver, the main organ capable of metabolizing this simple carbohydrate, perturbs glucose metabolism and glucose uptake pathways, and leads to a significantly enhanced rate of de novo lipogenesis and triglyceride (TG) synthesis, driven by the high flux of glycerol and acyl portions of TG molecules from fructose catabolism. These metabolic disturbances appear to underlie the induction of insulin resistance commonly observed with high fructose feeding in both humans and animal models. Fructose-induced insulin resistant states are commonly characterized by a profound metabolic dyslipidemia, which appears to result from hepatic and intestinal overproduction of atherogenic lipoprotein particles. Thus, emerging evidence from recent epidemiological and biochemical studies clearly suggests that the high dietary intake of fructose has rapidly become an important causative factor in the development of the metabolic syndrome. There is an urgent need for increased public awareness of the risks associated with high fructose consumption and greater efforts should be made to curb the supplementation of packaged foods with high fructose additives. The present review will discuss the trends in fructose consumption, the metabolic consequences of increased fructose intake, and the molecular mechanisms leading to fructose-induced lipogenesis, insulin resistance and metabolic dyslipidemia.
Basciano
Heather
H
Clinical Biochemistry Division, Department of Laboratory Medicine and Pathobiology, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada. khosrow.adeli@sickkids.ca.
Federico
Lisa
L
Adeli
Khosrow
K
Diabetes Metab Res Rev. 2002 Sep-Oct;18(5):345-56
12397577
Diabetes Metab. 2001 Apr;27(2 Pt 2):261-70
11452220
Eur J Biochem. 1990 Jun 20;190(2):427-33
2194804
Pediatrics. 2001 Sep;108(3):712-8
11533341
Am J Clin Nutr. 2002 Nov;76(5):911-22
12399260
Diabetologia. 1997 Feb;40(2):232-7
9049486
Diabetes Care. 1999 Mar;22(3):484-90
10097933
J Biol Chem. 2004 Jun 11;279(24):25164-71
15066988
J Clin Endocrinol Metab. 2000 Dec;85(12):4515-9
11134101
Diabetes. 2002 Apr;51(4):1035-41
11916923
J Nutr. 2002 May;132(5):918-23
11983814
Fed Proc. 1970 May-Jun;29(3):1302-7
4245709
Am J Clin Nutr. 1989 Jun;49(6):1155-63
2658534
Curr Opin Clin Nutr Metab Care. 2003 Jul;6(4):441-8
12806219
J Nutr. 1989 Sep;119(9):1304-10
2795244
Nature. 2001 Dec 13;414(6865):782-7
11742409
Am J Clin Nutr. 2003 Oct;78(4):873S-880S
14522752
Metabolism. 2005 May;54(5):689-97
15877301
Am J Physiol Endocrinol Metab. 2002 Sep;283(3):E545-55
12169448
Metabolism. 1996 Dec;45(12):1547-50
8969290
Nutr Cancer. 2003;45(1):46-52
12791504
Semin Liver Dis. 2001;21(1):89-104
11296700
Am J Clin Nutr. 1993 Nov;58(5 Suppl):810S-814S
8213614
J Clin Invest. 1993 Jul;92(1):141-6
8325978
Cater Health. 1988;1(1):51-71
10292082
Diabetes Metab Rev. 1992 Dec;8(4):389-404
1307526
J Biol Chem. 2004 May 21;279(21):22404-11
14988395
JAMA. 2001 Sep 12;286(10):1195-200
11559264
J Am Coll Nutr. 1987 Feb;6(1):11-7
3034993
J Biol Chem. 2002 Jan 4;277(1):793-803
11598116
Curr Opin Lipidol. 2002 Feb;13(1):51-9
11790963
Diabetes. 2002 Apr;51(4):1233-9
11916950
J Lipid Res. 1995 May;36(5):1073-81
7658155
Metabolism. 2003 Nov;52(11):1491-5
14624412
J Clin Invest. 1998 Jan 1;101(1):1-9
9421459
J Nutr. 2002 Nov;132(11):3379-82
12421854
J Biol Chem. 2000 Mar 24;275(12):8416-25
10722675
Hypertension. 1987 Nov;10(5):512-6
3311990
Endocrinology. 1994 Dec;135(6):2369-74
7988419
Am J Clin Nutr. 1988 Mar;47(3):406-12
3348153
Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12737-42
10535992
J Biol Chem. 1999 Aug 27;274(35):24714-20
10455139
Prev Med. 1995 May;24(3):308-15
7644455
Curr Opin Lipidol. 2001 Aug;12(4):395-404
11507324
Endocr J. 1997 Apr;44(2):239-45
9228459
Circulation. 1996 Jan 1;93(1):54-9
8616941
J Diabetes Complications. 2002 Jan-Feb;16(1):72-80
11872372
Am J Clin Nutr. 2004 Oct;80(4):1081; author reply 1081-2
15447924
J Biol Chem. 2003 Oct 31;278(44):43095-101
12941932
J Biol Chem. 2002 Aug 30;277(35):31646-55
12070142
FASEB J. 1990 Jun;4(9):2652-60
2189777
Int J Obes Relat Metab Disord. 1999 Feb;23(2):180-9
10078854
Twin Res. 2001 Feb;4(1):41-7
11665324
J Am Diet Assoc. 2004 Feb;104(2):255-75
14760578
Am J Clin Nutr. 2002 Nov;76(5):1023-30
12399274
J Biol Chem. 1999 Oct 15;274(42):30028-32
10514488
Diabetes Care. 2000 Sep;23(9):1278-83
10977060
JAMA. 1999 Oct 27;282(16):1519-22
10546690
Regul Toxicol Pharmacol. 1999 Apr;29(2 Pt 2):S83-93
10341166
J Nutr. 2003 Jun;133(6):1903-8
12771337
Diabetes Care. 1995 Aug;18(8):1104-12
7587845
Annu Rev Nutr. 1986;6:211-24
3524617
Exp Diabesity Res. 2004 Jul-Sep;5(3):195-200
15512787
Mol Cell Biochem. 2004 Jun;261(1-2):23-33
15362482
Cell. 1997 May 2;89(3):331-40
9150132
J Am Diet Assoc. 2002 Sep;102(9):1234-9
12792618
Diabetes Care. 1997 Nov;20(11):1664-9
9353605
Am J Clin Nutr. 1993 Nov;58(5 Suppl):754S-765S
8213607
Braz J Med Biol Res. 2000 Dec;33(12):1421-7
11105093
Nutr Neurosci. 2002 Oct;5(5):359-62
12385599
Taiwan Yi Xue Hui Za Zhi. 1989 Sep;88(9):883-5
2695593
Am J Clin Nutr. 2004 Oct;80(4):1043-9
15447918
Am J Clin Nutr. 1994 Mar;59(3 Suppl):747S-752S
8116560
Am J Hypertens. 2003 Nov;16(11 Pt 1):973-8
14573337
Diabetes. 2003 May;52(5):1073-80
12716735
Am J Physiol Endocrinol Metab. 2002 May;282(5):E1180-90
11934685
Metabolism. 2002 Aug;51(8):949-57
12145765
J Biol Chem. 1998 Oct 30;273(44):29164-71
9786926
Am J Clin Nutr. 2002 Oct;76(4):721-9
12324283
Am J Clin Nutr. 2000 Feb;71(2):412-33
10648253
Diabetes Obes Metab. 2004 May;6(3):200-7
15056128
Biochem J. 1992 Mar 15;282 ( Pt 3):753-7
1554357
J Clin Endocrinol Metab. 2004 Jun;89(6):2963-72
15181085
Horm Metab Res. 1985 Jun;17(6):285-8
4018717
Am J Crit Care. 2003 Mar;12(2):167-70
12625176
J Nutr Health Aging. 2001;5(3):144-9
11458283
Am J Clin Nutr. 2004 Apr;79(4):537-43
15051594
Am J Clin Nutr. 1992 Apr;55(4):851-6
1550068
JAMA. 2001 May 16;285(19):2486-97
11368702
Nat Med. 2002 Nov;8(11):1288-95
12368907
J Lab Clin Med. 1996 Aug;128(2):208-13
8765217
J Nutr. 2003 Jan;133(1):32-7
12514263
Vnitr Lek. 1997 Sep;43(9):566-73
9750464
West J Med. 2000 Dec;173(6):378-83
11112748
J Biol Chem. 2000 Oct 27;275(43):33302-7
10915800
Obes Rev. 2000 Oct;1(2):57-9
12119987
Int Z Vitam Ernahrungsforsch Beih. 1976;15:295-324
783058
Nutr Rev. 2003 May;61(5 Pt 2):S17-26
12828188
Int J Obes Relat Metab Disord. 1992 May;16(5):321-33
1319966
Diabetes. 2002 Jun;51(6):1722-8
12031958
Obes Res. 1995 Sep;3 Suppl 2:195S-198S
8581776
Clin Biochem. 2003 Sep;36(6):413-20
12951167
Nutr Rev. 2004 Apr;62(4):153-9
15141431
Arterioscler Thromb Vasc Biol. 2004 Apr;24(4):644-9
14715643
Front Biosci. 2003 Jan 01;8:d464-76
12456312
Biochim Biophys Acta. 2000 Jun 26;1486(1):72-83
10856714
J Nutr. 1982 Aug;112(8):1546-54
7047694
Am J Clin Nutr. 1981 Mar;34(3):362-6
6259925
J Biol Chem. 1995 Oct 27;270(43):25578-83
7592729
Am J Clin Nutr. 1995 Apr;61(4 Suppl):996S-1000S
7900699
J Nutr. 2001 Aug;131(8):2074-7
11481396
Obes Rev. 2002 May;3(2):59-68
12120421
Am J Clin Nutr. 1997 Nov;66(5):1072-85
9356523
Am J Physiol Endocrinol Metab. 2000 Oct;279(4):E907-11
11001775
Endocrinology. 2004 Feb;145(2):548-55
14576175
Psychoneuroendocrinology. 2005 Jan;30(1):1-10
15358437
Am J Physiol. 1986 Mar;250(3 Pt 1):E325-30
3513615
Eur J Clin Nutr. 1992 Oct;46 Suppl 2:S91-101
1330533
Am J Clin Nutr. 2004 May;79(5):774-9
15113714
Diabetes. 2004 Mar;53(3):560-9
14988238